Michael Kaseta insider trades

Open-market stock purchases and sales by Michael Kaseta, CFO and COO at Liquidia Corp, from SEC Form 4 filings since Nov 30, 2017.

Recent trades

DateStockTradeValue
Apr 15, 2026LQDA Liquidia CorpSold$363K
Apr 15, 2026LQDA Liquidia CorpSold$3.5M
Apr 15, 2026LQDA Liquidia CorpSold$1.7M
Apr 15, 2026LQDA Liquidia CorpBought (not open market)—
Apr 14, 2026LQDA Liquidia CorpSold$120K
Apr 14, 2026LQDA Liquidia CorpBought (not open market)—
Apr 13, 2026LQDA Liquidia CorpSold$727K
Apr 10, 2026LQDA Liquidia CorpSold$956K
Apr 10, 2026LQDA Liquidia CorpBought (not open market)—
Apr 10, 2026LQDA Liquidia CorpBought (not open market)—
Apr 10, 2026LQDA Liquidia CorpBought (not open market)—
Apr 9, 2026LQDA Liquidia CorpSold$5.4M
Apr 9, 2026LQDA Liquidia CorpBought (not open market)—
Apr 9, 2026LQDA Liquidia CorpBought (not open market)—
Apr 9, 2026LQDA Liquidia CorpBought (not open market)—
Apr 9, 2026LQDA Liquidia CorpBought (not open market)—
Apr 9, 2026LQDA Liquidia CorpBought (not open market)—
Mar 2, 2026LQDA Liquidia CorpSold$35.6K
Feb 27, 2026LQDA Liquidia CorpBought (not open market)—
Jan 30, 2026HRTX Heron Therapeutics, Inc /de/Bought (not open market)—
Jan 16, 2026LQDA Liquidia CorpBought (not open market)—
Jan 16, 2026LQDA Liquidia CorpBought (not open market)—
Jan 12, 2026LQDA Liquidia CorpSold$1.4M
Jan 9, 2026LQDA Liquidia CorpBought (not open market)—
Jan 9, 2026LQDA Liquidia CorpBought (not open market)—

Companies traded

  • LQDA Liquidia Corp: 4 buys, 28 sales, last Apr 15, 2026
  • HRTX Heron Therapeutics, Inc /de/: other filings, last Jan 30, 2026
  • ALIM Alimera Sciences Inc: other filings, last Sep 16, 2024
  • ARLZ Aralez Pharmaceuticals Inc: other filings, last Mar 15, 2018

Get free alerts when Michael Kaseta files a new trade →